Matches in Wikidata for { <http://www.wikidata.org/entity/Q60707174> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q60707174 description "article scientifique publié en 2018" @default.
- Q60707174 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q60707174 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60707174 description "scientific article published on 13 June 2018" @default.
- Q60707174 description "wetenschappelijk artikel" @default.
- Q60707174 description "наукова стаття, опублікована у вересні 2018" @default.
- Q60707174 name "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L" @default.
- Q60707174 name "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide" @default.
- Q60707174 type Item @default.
- Q60707174 label "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L" @default.
- Q60707174 label "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide" @default.
- Q60707174 prefLabel "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L" @default.
- Q60707174 prefLabel "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide" @default.
- Q60707174 P1433 Q60707174-8DC5A1B7-C8A1-406D-9C20-87065A883DB0 @default.
- Q60707174 P1476 Q60707174-4A5707BB-E6B6-4CF2-814F-A08F51D62FD5 @default.
- Q60707174 P2093 Q60707174-0E47D808-0CFD-4920-96CD-00E15535646F @default.
- Q60707174 P2093 Q60707174-145F718A-FEB9-4594-8B89-44785A40946D @default.
- Q60707174 P2093 Q60707174-8031256E-AD69-4297-89F0-D1E6E17B8697 @default.
- Q60707174 P2093 Q60707174-9D5F6D8D-968D-4961-8391-8ECD8778ACCE @default.
- Q60707174 P2860 Q60707174-04292DC1-7D75-40EA-8358-F5EA6608BD82 @default.
- Q60707174 P2860 Q60707174-0A09E6BC-A6B5-4812-9EFB-AF606D423B17 @default.
- Q60707174 P2860 Q60707174-25B76A2B-18ED-4454-9875-A7CB9B376922 @default.
- Q60707174 P2860 Q60707174-5039DC06-A125-4CD7-BD12-41B39E940082 @default.
- Q60707174 P2860 Q60707174-750934BB-4D53-40F0-8319-178259DFD597 @default.
- Q60707174 P2860 Q60707174-8AC625FA-0E1C-49A8-9064-B11F06CCFF34 @default.
- Q60707174 P2860 Q60707174-8F267C91-6C43-471B-84C0-5B4C2358C255 @default.
- Q60707174 P2860 Q60707174-C91B0403-E977-448D-9CA9-3B0FCF884FA6 @default.
- Q60707174 P2860 Q60707174-D5593934-EE3B-44E5-88A7-DE0861CFD8E0 @default.
- Q60707174 P2860 Q60707174-D966962A-52FE-418D-9A17-3043A480B71F @default.
- Q60707174 P2860 Q60707174-F7676CFC-8535-46E4-80D3-B8D0FE6A7FFE @default.
- Q60707174 P2860 Q60707174-FCA02D77-88BB-4D83-8FB3-C544DF87F641 @default.
- Q60707174 P304 Q60707174-D583FDF6-F143-4F64-8F7E-1B427F655899 @default.
- Q60707174 P31 Q60707174-1A16B1CE-F8C4-404B-9828-38516F8ACBE4 @default.
- Q60707174 P356 Q60707174-1B7E00DE-483B-4864-B74B-CEE6DBA32B8F @default.
- Q60707174 P407 Q60707174-B1C7D811-77BF-4A1A-9D2F-BEF1FED1BA54 @default.
- Q60707174 P433 Q60707174-20BC87CB-342B-42D2-AEBB-0EA40F1EE0A0 @default.
- Q60707174 P478 Q60707174-0EDD7E75-F668-444E-B01A-FA3EA8B13737 @default.
- Q60707174 P50 Q60707174-5AFC3B1A-99D7-4B03-8A57-AEAF811C8023 @default.
- Q60707174 P50 Q60707174-B6B532C9-40F0-43C6-8011-964A0750E1A8 @default.
- Q60707174 P50 Q60707174-D4D769CF-C564-4B4A-8B40-6E14ED1169A4 @default.
- Q60707174 P577 Q60707174-78853F4E-3DC8-44D4-ABDD-8A72272A160A @default.
- Q60707174 P698 Q60707174-5AB9D192-FC7B-41B5-BE90-27FAAA72C0E7 @default.
- Q60707174 P921 Q60707174-0AD4680D-45D7-4EC7-AE07-FE0F8BCC93B7 @default.
- Q60707174 P921 Q60707174-4B7F2C90-B1AF-4F3A-A1D1-C1E8EBAF385C @default.
- Q60707174 P932 Q60707174-7F5A5A8B-F155-4E6D-B541-789DB7CAF585 @default.
- Q60707174 P356 DOM.13368 @default.
- Q60707174 P698 29785837 @default.
- Q60707174 P1433 Q5270109 @default.
- Q60707174 P1476 "More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L" @default.
- Q60707174 P2093 "Erika Soltes Rak" @default.
- Q60707174 P2093 "Minzhi Liu" @default.
- Q60707174 P2093 "Raffaele Napoli" @default.
- Q60707174 P2093 "Vanita R Aroda" @default.
- Q60707174 P2860 Q24652963 @default.
- Q60707174 P2860 Q29615973 @default.
- Q60707174 P2860 Q36712701 @default.
- Q60707174 P2860 Q37345822 @default.
- Q60707174 P2860 Q38040314 @default.
- Q60707174 P2860 Q38208122 @default.
- Q60707174 P2860 Q40536743 @default.
- Q60707174 P2860 Q45697142 @default.
- Q60707174 P2860 Q47716792 @default.
- Q60707174 P2860 Q51278923 @default.
- Q60707174 P2860 Q51280414 @default.
- Q60707174 P2860 Q53261592 @default.
- Q60707174 P304 "2314-2318" @default.
- Q60707174 P31 Q13442814 @default.
- Q60707174 P356 "10.1111/DOM.13368" @default.
- Q60707174 P407 Q1860 @default.
- Q60707174 P433 "9" @default.
- Q60707174 P478 "20" @default.
- Q60707174 P50 Q48135786 @default.
- Q60707174 P50 Q57368642 @default.
- Q60707174 P50 Q87728507 @default.
- Q60707174 P577 "2018-06-13T00:00:00Z" @default.
- Q60707174 P698 "29785837" @default.
- Q60707174 P921 Q417317 @default.
- Q60707174 P921 Q7240673 @default.
- Q60707174 P932 "6099242" @default.